A trial looking at the V212 vaccine to prevent shingles in people having chemotherapy (V212-011)

Overview

Cancer types:

Acute leukaemia, Blood cancers, Cell type, Chronic leukaemia, High grade lymphoma, Hodgkin lymphoma, Leukaemia, Low grade lymphoma, Lymphoma, Myeloma, Non-Hodgkin lymphoma (NHL)

Status:

Results

Phase:

Phase 3

Details

This trial was done to see if a vaccine called V212 could help prevent people getting shingles while they are having treatment.

It was open in various countries for people having chemotherapy for or . In the UK it was only open for people with a blood cancer (leukaemia, lymphoma or myeloma).

It was open for people to join between 2011 and 2017. The team published the results in 2019. There is a link to more information in the ‘Summary of results’ section below.

Recruitment start: 27 June 2011

Recruitment end: 11 April 2017